Suchergebnisse - "COVID-19 Vaccines"

PubPharm (1.565)

71

A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides

enthalten in: Vaccine | 2024

von Ratishvili, T. | Quach, H. | Haralambieva, I. | +4

72

Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients

enthalten in: Viruses | 2024

von Messchendorp, A. | Sanders, J. | Abrahams, A. | +14

73

Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia

enthalten in: Experimental hematology | 2024

von Cosenza, L. | Marzaro, G. | Zurlo, M. | +4

74

Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86

enthalten in: Cell host & microbe | 2024

von Sette, A. | Sidney, J. | Grifoni, A.

75

Adjuvant activities of immunostimulating natural products : Astragalus membranaceus (Fisch.) Bge. and Coriolus versicolor in BNT162b2 vaccination against COVID-19 infection

enthalten in: Journal of leukocyte biology | 2024

von Chan, B. | Li, P. | Tsang, M. | +10

76

Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques

enthalten in: Nature communications | 2024

von Sankhala, R. | Lal, K. | Jensen, J. | +48

77

Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients

enthalten in: Clinical and experimental rheumatology | 2024

von Ammitzbøll, C. | Thomsen, M. | Andersen, J. | +18

78

Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination

enthalten in: Virus research | 2024

von Ota, K. | Sakai, H. | Sasaki, D. | +10

79

Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults : a randomized, double-blind, positive-parallel-controlled study

enthalten in: Expert review of vaccines | 2024

von Tang, R. | Zeng, Y. | Zhou, Y. | +8

80

Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program

enthalten in: Frontiers in immunology | 2024

von van Leeuwen, L. | Grobben, M. | GeurtsvanKessel, C. | +36